Skip to main content
Erschienen in: Intensive Care Medicine 3/2012

01.03.2012 | Experimental

Vasopressin improves systemic hemodynamics without compromising mesenteric perfusion in the resuscitation of asphyxiated newborn piglets: a dose–response study

verfasst von: Douglas C. Cheung, Richdeep S. Gill, Jiang-Qin Liu, Namdar Manouchehri, Consolato Sergi, David Bigam, Po-Yin Cheung, Bryan J. Dicken

Erschienen in: Intensive Care Medicine | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hypoxia and reoxygenation (H-R) contributes to multi-organ failure in neonates, including cardiac and systemic complications. Use of vasopressin, an endogenous vasoconstrictive hormone commonly used to treat refractory hypotension in adults, in neonates with shock remains limited and not yet fully studied. We hypothesize that vasopressin will improve mean arterial pressure (MAP), without compromising cardiac, mesenteric, or carotid hemodynamics using a swine model of neonatal asphyxia.

Methods

Anesthetized piglets (1–4 days old, 1.4–2.5 kg, n = 33) were instrumented for continuous monitoring of cardiac index (CI), MAP, and regional arterial [common carotid (CA), superior mesenteric (SMA)] flow. The animals underwent hypoxia at 10–15% oxygen (2 h) followed by reoxygenation at 100% (0.5 h) and 21% (3.5 h) oxygen. Vasopressin infusion was initiated after 2 h reoxygenation at 0.005, 0.01, or 0.02 units/kg/h i.v. for 2 h (n = 7/group). H-R control (saline infusion) and sham-operated (non-asphyxiated) groups were also included. Intermittent blood gases and plasma lactate were determined as well as tissue lactate levels. Statistical significance was determined using ANOVA.

Results

All H-R piglets had hypotension (36–49% decrease in MAP) and decreased regional blood flows (CA −28 to −34%, SMA −12 to +32% of baseline) at 2 h reoxygenation. Vasopressin infusion dose-dependently increased MAP (14% at 0.02 units/kg/h, P < 0.05) without significant detrimental effects in CI, regional blood flows, and intestinal or cerebral tissue lactate levels.

Conclusions

Vasopressin treatment causes a dose-dependent baro-specific effect, while preserving cardiac function and cerebral and mesenteric hemodynamics in newborn piglets following H-R.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Irazuzta J, Sullivan KJ, Garcia PC, Piva JP (2007) Pharmacologic support of infants and children in septic shock. J Pediatr (Rio J) 83:S36–S45CrossRef Irazuzta J, Sullivan KJ, Garcia PC, Piva JP (2007) Pharmacologic support of infants and children in septic shock. J Pediatr (Rio J) 83:S36–S45CrossRef
2.
Zurück zum Zitat Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688PubMedCrossRef Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, Doctor A, Davis A, Duff J, Dugas MA, Duncan A, Evans B, Feldman J, Felmet K, Fisher G, Frankel L, Jeffries H, Greenwald B, Gutierrez J, Hall M, Han YY, Hanson J, Hazelzet J, Hernan L, Kiff J, Kissoon N, Kon A, Irazuzta J, Lin J, Lorts A, Mariscalco M, Mehta R, Nadel S, Nguyen T, Nicholson C, Peters M, Okhuysen-Cawley R, Poulton T, Relves M, Rodriguez A, Rozenfeld R, Schnitzler E, Shanley T, Kache S, Skippen P, Torres A, von Dessauer B, Weingarten J, Yeh T, Zaritsky A, Stojadinovic B, Zimmerman J, Zuckerberg A (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37:666–688PubMedCrossRef
3.
Zurück zum Zitat Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877–887PubMedCrossRef Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D, VASST Investigators (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877–887PubMedCrossRef
4.
Zurück zum Zitat Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D’Alessandro M, Van Aken H, Pietropaoli P, Westphal M (2009) Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 13:R130PubMedCrossRef Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D’Alessandro M, Van Aken H, Pietropaoli P, Westphal M (2009) Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study. Crit Care 13:R130PubMedCrossRef
5.
Zurück zum Zitat Morelli A, Ertmer C, Pietropaoli P, Westphal M (2009) Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. Expert Opin Pharmacother 10:2569–2575PubMedCrossRef Morelli A, Ertmer C, Pietropaoli P, Westphal M (2009) Terlipressin: a promising vasoactive agent in hemodynamic support of septic shock. Expert Opin Pharmacother 10:2569–2575PubMedCrossRef
6.
Zurück zum Zitat Filippi L, Poggi C, Serafini L, Fiorini P (2008) Terlipressin as rescue treatment of refractory shock in a neonate. Acta Paediatr 97:500–502PubMedCrossRef Filippi L, Poggi C, Serafini L, Fiorini P (2008) Terlipressin as rescue treatment of refractory shock in a neonate. Acta Paediatr 97:500–502PubMedCrossRef
7.
Zurück zum Zitat Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z, Paret G (2004) Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 5:116–118PubMedCrossRef Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z, Paret G (2004) Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 5:116–118PubMedCrossRef
8.
Zurück zum Zitat Meyer S, Gottschling S, Baghai A, Wurm D, Gortner L (2006) Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care 10:R71PubMedCrossRef Meyer S, Gottschling S, Baghai A, Wurm D, Gortner L (2006) Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care 10:R71PubMedCrossRef
9.
Zurück zum Zitat Meyer S, Löffler G, Polcher T, Gottschling S, Gorner L (2006) Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants. Acta Paediatr 95:1309–1312PubMedCrossRef Meyer S, Löffler G, Polcher T, Gottschling S, Gorner L (2006) Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants. Acta Paediatr 95:1309–1312PubMedCrossRef
10.
Zurück zum Zitat Rodríguez-Núñez A, Fernández-Sanmartín M, Martinón-Torres F, González-Alonso N, Martinón-Sánchez JM (2004) Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 30:477–480PubMedCrossRef Rodríguez-Núñez A, Fernández-Sanmartín M, Martinón-Torres F, González-Alonso N, Martinón-Sánchez JM (2004) Terlipressin for catecholamine-resistant septic shock in children. Intensive Care Med 30:477–480PubMedCrossRef
11.
Zurück zum Zitat Liedel JL, Meadow W, Nachman J, Koogler T, Kahana MD (2002) Use of vasopressin in refractory hypotension in children with vasodilatory shock: five cases and a review of the literature. Pediatr Crit Care Med 3:15–18PubMedCrossRef Liedel JL, Meadow W, Nachman J, Koogler T, Kahana MD (2002) Use of vasopressin in refractory hypotension in children with vasodilatory shock: five cases and a review of the literature. Pediatr Crit Care Med 3:15–18PubMedCrossRef
12.
Zurück zum Zitat Haase E, Bigam DL, Nakonechny QB, Jewell LD, Korbutt G, Cheung PY (2004) Resuscitation with 100% oxygen causes intestinal glutathione oxidation and reoxygenation injury in asphyxiated newborn piglets. Ann Surg 240:364–373PubMedCrossRef Haase E, Bigam DL, Nakonechny QB, Jewell LD, Korbutt G, Cheung PY (2004) Resuscitation with 100% oxygen causes intestinal glutathione oxidation and reoxygenation injury in asphyxiated newborn piglets. Ann Surg 240:364–373PubMedCrossRef
13.
Zurück zum Zitat Park PO, Haglund U, Bulkley GB, Fält K (1990) The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 107:574–580PubMed Park PO, Haglund U, Bulkley GB, Fält K (1990) The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery 107:574–580PubMed
14.
Zurück zum Zitat Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D (2006) Does dopamine administration in shock influence outcome? Results of the sepsis occurrence in acutely Ill patients (SOAP) study. Crit Care Med 34:589–597PubMedCrossRef Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, De Backer D, Payen D (2006) Does dopamine administration in shock influence outcome? Results of the sepsis occurrence in acutely Ill patients (SOAP) study. Crit Care Med 34:589–597PubMedCrossRef
15.
Zurück zum Zitat Tourneux P, Rakza T, Abazine A, Krim G, Storme L (2008) Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants. Acta Paediatr 97:177–180PubMedCrossRef Tourneux P, Rakza T, Abazine A, Krim G, Storme L (2008) Noradrenaline for management of septic shock refractory to fluid loading and dopamine or dobutamine in full-term newborn infants. Acta Paediatr 97:177–180PubMedCrossRef
16.
Zurück zum Zitat Zhang J, Penny DJ, Kim NS, Yu VY, Smolich JJ (1999) Mechanisms of blood pressure increase induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fetal Neonatal Ed 81:F99–F104PubMedCrossRef Zhang J, Penny DJ, Kim NS, Yu VY, Smolich JJ (1999) Mechanisms of blood pressure increase induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fetal Neonatal Ed 81:F99–F104PubMedCrossRef
17.
Zurück zum Zitat Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F (2006) Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. Pediatrics 117:1213–1222CrossRef Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F (2006) Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. Pediatrics 117:1213–1222CrossRef
Metadaten
Titel
Vasopressin improves systemic hemodynamics without compromising mesenteric perfusion in the resuscitation of asphyxiated newborn piglets: a dose–response study
verfasst von
Douglas C. Cheung
Richdeep S. Gill
Jiang-Qin Liu
Namdar Manouchehri
Consolato Sergi
David Bigam
Po-Yin Cheung
Bryan J. Dicken
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Intensive Care Medicine / Ausgabe 3/2012
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-011-2437-4

Weitere Artikel der Ausgabe 3/2012

Intensive Care Medicine 3/2012 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.